Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
amgen
boston blog main
boston top stories
cholesterol
3
×
inclisiran
life sciences
national blog main
national top stories
new york blog main
3
×
new york top stories
praluent
regeneron pharmaceuticals
repatha
3
×
clinical trials
ldl
mt sinai hospital
new york
pcsk9
prashant vaishnava
san francisco blog main
san francisco top stories
sanofi
the medicines co.
alirocumab
alnylam pharmaceuticals
biotech
boulder/denver blog main
boulder/denver top stories
cardiac
cardiovascular
cause of death
cedar-sinai
circulation
clinical studies
data
david maron
detroit blog main
detroit top stories
esperion pharmaceuticals
evolocumab
What
cholesterol
drug
3
×
lowering
medco
medicines
twice
aces
announced
big
bringing
ceo
clears
closer
drugs
expensive
faces
fda
filing
financial
flexible
foe
healthcare
hint
inched
inclisiran
inhibitors
key
known
market
meant
medicine
morning
nasdaq
new
open
passed
pcsk
phase
positive
preps
Language
unset
Current search:
repatha
×
" new york blog main "
×
drug
×
cholesterol
×
@xconomy.com
4 years ago
MedCo Preps for FDA Filing as Cholesterol Drug Clears Last Two Tests
@xconomy.com
5 years ago
As Cholesterol Drug Aces Big Test, MedCo CEO Open to Flexible Pricing
@xconomy.com
5 years ago
New PCSK9 Cholesterol Drug Faces Tough Foe. (Hint: Not Cholesterol.)